Clinical Trials Sponsored by Ceek Enterprises

Total 187 results

Ceek Enterprises

Completed

Evaluation of the Nella Women's Care Line

GYN Disorders

United States
Universal Enterprises

Unknown

Bioequivalence of Phenazopyridine HCl in Healthy Volunteers

Human Volunteers

Pakistan
Anova Enterprises, Inc

Recruiting

AnovaOS Network Powered Patient Registry

Neoplasms | Infectious Disease | External Causes of Morbidity and Mortality | Pregnancy, Childbirth and the Puerperium | Diseases of the Blood and Blood-Forming Organs and Certain Disorders Involving the Immune Mechanism (D50-D89) | Endocrine, Nutritional and Metabolic Diseases (E00-E89) | Mental... and other conditions

United States
Lander Enterprises, LLC

Completed

Plaque and Gingivitis Evaluation of a U-Shaped Toothbrush in a 30-Day Model

Plaque Induced Gingivitis

United States
NTK Enterprises, Inc.

Terminated

Hyperopia Correction Using the NTK Optimal Keratoplasty (Opti-K) System

Hyperopia

United States
Piramal Enterprises Limited

Completed

A Study to Assess Radiation Induced Mucositis in Patients of Head and Neck Cancer Administered Chemo-Radiation With or Without P276-00

Radiation Induced Mucositis in Head and Neck Cancer

India
Piramal Enterprises Limited

Completed

A Phase II Clinical Trial to Study the Efficacy and Safety of a New Drug P276-00 in Treatment of Recurrent and/or Locally Advanced Head and Neck Cancer (MONARCH)

Squamous Cell Carcinoma of Head and Neck

India
Piramal Enterprises Limited

Terminated

Clinical Trial to Study the Safety Tolerability, Pharmacokinetics, Food Effect & Pharmacodynamics of a New Compound P7435 in Healthy, Overweight and/or Obese Subjects

Healthy, Overweight and/or Obese Subjects

India
Piramal Enterprises Limited

Terminated

Study of P3914 to Evaluate the Safety, Tolerability, Food Effect & Pharmacokinetics in Healthy Male Subjects and Efficacy & Safety of P3914 in Patients With Acute Dental Pain

Acute Dental Pain
Piramal Enterprises Limited

Completed

Study To Evaluate Safety and Efficacy of P276-00 in Subjects With Refractory Multiple Myeloma

Relapsed and/or Refractory Multiple Myeloma

India
Piramal Enterprises Limited

Completed

Safety and Efficacy Study of P276-00 in Combination With Gemcitabine in Patients With Advanced Pancreatic Cancer (SAVIOR)

Pancreatic Cancer

India
Piramal Enterprises Limited

Completed

Open Label Phase I Study of P276-00 in Patients With Advanced Refractory Neoplasms

Neoplasm

Canada, India
Innovation Hub Enterprises

Not yet recruiting

COPD Remote Patient Monitoring Through Connected Devices

Chronic Obstructive Pulmonary Disease

United States
Piramal Enterprises Limited

Suspended

Clinical Study of Oral PI3K/mTOR Inhibitor in Patients With Advanced Refractory Solid Tumors

Advanced Refractory Solid Tumors

United States, India
Piramal Enterprises Limited

Suspended

Clinical Study of Oral IGF-1R Inhibitor in Subjects With Advanced Refractory Solid Tumors

Advanced Refractory Solid Tumors

United States, India
Piramal Enterprises Limited

Terminated

A Clinical Trial Comparing Gemcitabine and Carboplatin With and Without P276-00 in Subjects With Metastatic Triple Negative Breast Cancer, With a Run-in of Escalating Dose of P276-00 Added to Gemcitabine and Carboplatin

Breast Cancer

United States
Piramal Enterprises Limited

Terminated

A Clinical Trial to Study the Efficacy, Safety, Tolerability and Pharmacokinetics of P2202 in Patients of Type 2 Diabetes

Type 2 Diabetes Mellitus

Canada
Piramal Enterprises Limited

Completed

Safety and Efficacy Study of P276-00 in Combination With Radiation in Subjects With Advanced Head and Neck Cancer (SPARK)

Squamous Cell Carcinoma of Head and Neck

India
Piramal Enterprises Limited

Completed

A Study Of Selective Cyclin Dependent Kinase Inhibitor P1446A-05 In Subjects With Advanced Refractory Malignancies (Serenity)

Solid Tumor | Hematologic Malignancy

India
Lander Enterprises, LLC

Completed

Plaque Removal Efficacy of a U-Shaped Sonic Power Toothbrush in Children

Dental Plaque

United States
Medical Enterprises Ltd.

Terminated

Mitomycin C Intravesical Chemotherapy in Conjunction With Synergo® Radiofrequency-Induced Hyperthermia for Treatment of Carcinoma in Situ Non-Muscle Invasive Bladder Cancer Patients Unresponsive to Bacillus Calmette-Guérin, With or Without Papillary Tumors. (RITE-USA)

Urinary Bladder Cancer | Bladder Cancer | Malignant Tumor of Urinary Bladder | Bladder Neoplasm | Cancer of Bladder | Carcinoma in Situ of Bladder | Bladder Tumors | Cancer of the Bladder | Neoplasms, Bladder | Papillary Carcinoma of Bladder (Diagnosis) | BCG-Unresponsive Bladder Cancer

United States
Piramal Enterprises Limited

Completed

Efficacy Study Of P276-00 In Subjects Of Malignant Melanoma Positive For Cyclin D1 Expression (ENVER)

Melanoma

Australia, India, New Zealand
Piramal Enterprises Limited

Completed

A Phase IV Clinical Trial to Study the Safety, Tolerability and Efficacy of Tinefcon in Patients With Plaque Psoriasis

Plaque Psoriasis

India
Piramal Enterprises Limited

Completed

A Multicenter Phase I Clinical Study of a New Compound P1446A-05 in Patients With Advanced Refractory Malignancies

Cancer

Canada
Piramal Enterprises Limited

Terminated

A Phase II Study to Evaluate Efficacy and Safety of P276-00 in Relapsed and/or Refractory Mantle Cell Lymphoma

Mantle Cell Lymphoma

United States, India
Piramal Enterprises Limited

Withdrawn

Phase I Study for Safety and Efficacy of P276-00 in Subjects With Myeloma

Multiple Myeloma
Piramal Enterprises Limited

Terminated

Phase I Study of P276-00 in Patients With Advanced Refractory Neoplasms

Neoplasm

India
Baio Enterprises
Baio Institute

Active, not recruiting

Neuro Strengths-Based Approach to Autism (NSBAA)

Autism Spectrum Disorder

United States
Medical Enterprises Europe B.V.

Withdrawn

SHTC - EUROPE-1 Synergo Hyperthermia-Chemotherapy by European Urologists' Research Operation Preserving Evolution Study I (SHTC-EUROPE-1)

Neoplasms | Urologic Neoplasms | Urogenital Neoplasms | Neoplasms by Site | Urologic Diseases | Urinary Bladder Diseases | Urinary Bladder Neoplasms
FFF Enterprises
OMRIX Biopharmaceuticals

Completed

A Clinical Study of Intravenous Immunoglobulin (IGIV)

Immunologic Deficiency Syndromes

United States, Canada
Medical Enterprises Europe B.V.

Withdrawn

RITE-EUROPE (Radiofrequency-Induced Thermochemotherapy Effect-EUROPE)

Bladder Cancer
Pharmanex
Nu Skin Enterprises

Completed

Effects of a Nutritional Supplement Combination on Body Weight Management

Safety/Effacy

United States
Enterprise Therapeutics Ltd

Completed

A First in Human Study to Evaluate the Safety, Tolerability and Pharmacokinetics of Single and Multiple Ascending Doses of Inhaled ETD001 in Healthy Subjects

Cystic Fibrosis

United Kingdom
Medical Enterprises Europe B.V.

Terminated

Hyperthermia Treatment in Conjunction With Mitomycin C Versus Bacillus Calmette-Guérin Immunotherapy (BCG) for Superficial Bladder Cancer

Neoplasms | Urologic Neoplasms | Neoplasms by Site | Urologic Diseases | Urinary Bladder Diseases | Urinary Bladder Neoplasms | Urinary Bladder Cancer | Malignant Tumor of Urinary Bladder

Austria, Israel, Italy, Netherlands
Enterprise Therapeutics Ltd

Completed

A First in Human Study to Evaluate the Safety, Tolerability and Pharmacokinetics of Single and Multiple Ascending Doses of Inhaled ETD002 in Healthy Subjects

Healthy

United Kingdom
Stanford University
Nu Skin Enterprises

Completed

Pilot Investigation of a Multinutrient Supplement on Skin Aging and Aging Metabolites in Healthy Women

Skin Diseases

United States
Les Entreprises de Télémédecine

Completed

Teleconsultation in Ambulatory Care in France (TELET)

Telemedicine | Telehealth | Teleconsultation

France
HealthCare Global Enterprise Ltd.

Unknown

A Novel Modified Tracheo-Esophageal Voice Prosthesis for Total Laryngectomy Patients (TEP)

Laryngeal Cancer | Hypopharynx Cancer

India
Richever Enterprise Co., Ltd.

Unknown

Clinical Study for Development of Oral Galactose Single Point (OGSP) Solution (G.S.P. Oral Solution®)

Galactose Single Point (GSP), Residual Liver Function
Public Health Foundation Enterprises, Inc.

Recruiting

mHealth Systems Navigation- Breaking Systems Barriers for Trans Women Living With HIV (mSN)

Substance Use | Mental Health Issue

United States
HealthCare Global Enterprise Ltd.

Unknown

Role of Imaging to Predict the Deep Surgical Margin in Gingivobuccal Complex Tumors

Buccal Mucosa Cancer | Gingival Cancer

India
HealthCare Global Enterprise Ltd.

Unknown

Role of Neo-adjuvant Chemotherapy in Tongue Preservation in Locally Advanced Squamous Cell Carcinoma of Oral Tongue

Squamous Cell Carcinoma | Tongue Neoplasms | Anterior Tongue Squamous Cell Carcinoma

India
Silver Creek Pharmaceuticals

Recruiting

Study of the Safety and Neuroprotective Capacity of Scp776 in Acute Ischemic Stroke (ARPEGGIO)

Acute Ischemic Stroke (AIS)

United States
Massachusetts General Hospital
Nu Skin Enterprises

Completed

Correlation Between Skin Carotenoid Levels and Previous History of Skin Cancer

Skin Cancer | Basal Cell Carcinoma | Squamous Cell Carcinoma

United States
Red Nucleus Enterprise Solutions, LLC

Recruiting

NSAA NON-Interventional Study Protocol

Duchenne Muscular Dystrophy

United States
Johnson & Johnson Enterprise Innovation Inc.

Recruiting

Confocal Laser Endomicroscopy Nodule Localization by Robotic Bronchoscopy (CLEAR)

Lung Neoplasms

United States
Chen Yi Enterprise, Co., Ltd.

Completed

Effectiveness of Nanoone Woman Underwear Using in the Management of Dysmenorrhea

Dysmenorrhea

Taiwan
Cenk Gacemer

Completed

Comparison Of The Analgesic Efficacy Of IPACK (Interspace Between The Popliteal Artery And Capsule Of The Posterior Knee) Block Alone And IPACK Block Combined With Genicular Block In Patients Planned For Total Knee Arthroplasty

Anesthesia | Orthopedic Disorder | Knee Arthropathy | Pain, Joint

Turkey
Castle Creek Pharmaceuticals, LLC

Completed

Long Term Open-label Study Evaluating Safety of Diacerein 1% Ointment Topical Formulation in Subjects With Epidermolysis Bullosa Simplex

Epidermolysis Bullosa | Epidermolysis Bullosa Simplex

United States
Castle Creek Pharmaceuticals, LLC

Completed

A 4-Day Study to Evaluate the Photoxicity of Diacerein 1% Topical Ointment in Healthy Volunteers

Healthy

United States

3

Subscribe